Clinical Trial Update: A Study Evaluating MM-310 in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

This update reports a Phase 1 study evaluating MM-310 in patients with solid tumors. The listed indications include urothelial carcinoma, gastric carcinoma, squ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Ductal Adenocarcinoma
• Prostate Adenocarcinoma
• Small Cell Lung Cancer
• Squamous Cell Carcinoma of the Head and Neck
• Urothelial Carcinoma

Drugs mentioned

• MM-310

Snippet

Sponsor: Merrimack Pharmaceuticals | Conditions: Solid Tumors, Urothelial Carcinoma | Phase 1 | Status: UNKNOWN